...
机译:中国非小细胞肺癌化疗的临床疗效与安全性:在PRISMA指南后27例随机对照试验的系统审查与荟萃分析
Zunyi Med Univ Dept Gen Med Affiliated Hosp Zunyi 563003 Guizhou Peoples R China;
Zunyi Med Univ Dept Gen Med Affiliated Hosp Zunyi 563003 Guizhou Peoples R China;
Zunyi Med Univ Dept Gen Med Affiliated Hosp Zunyi 563003 Guizhou Peoples R China;
Zunyi Med Univ Evidence Based Med Ctr MOE Virtual Res Ctr Evidence Based Med Affiliated Hosp;
Zunyi Med Univ Dept Gen Med Affiliated Hosp Zunyi 563003 Guizhou Peoples R China;
Zunyi Med Univ GCP Ctr Affiliated Hosp Zunyi 563003 Guizhou Peoples R China;
Zunyi Med Univ GCP Ctr Affiliated Hosp Zunyi 563003 Guizhou Peoples R China;
Zunyi Med Univ Sch Management Zunyi 563003 Guizhou Peoples R China;
Zunyi Med Univ Dept Immunol Special Key Lab Gene Detect &
Therapy Guizhou Pro Zunyi 563000;
Zunyi Med Univ Key Lab Cell Engn Guizhou Prov Affiliated Hosp Zunyi 519000 Guizhou Peoples R;
Wuhan Univ Ctr Evidence Based &
Translat Med Zhongnan Hosp Wuhan 430071 Hubei Peoples R China;
Taizhou Univ Dept Oncol Med Coll Affiliated Taizhou Municipal Hosp Taizhou 318000 Zhejiang;
Zunyi Med Univ Dept Gen Med Affiliated Hosp Zunyi 563003 Guizhou Peoples R China;
Non-small cell lung cancer; Synthetic thymic peptides; Thymosin alpha 1; Thymopentin; Randomized controlled trial; Meta-analysis;
机译:中国非小细胞肺癌化疗的临床疗效与安全性:在PRISMA指南后27例随机对照试验的系统审查与荟萃分析
机译:艾迪注射液能否在接受铂类化学疗法治疗的非小细胞肺癌患者中恢复细胞免疫力并提高临床疗效?根据PRISMA指南对17项随机对照试验进行荟萃分析
机译:康交化疗治疗非小细胞肺癌的施用疗效和安全性:随机对照试验的系统回顾与荟萃分析
机译:细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
机译:表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物:随机对照试验的系统评价。
机译:艾迪注射液能否在接受铂类化学疗法治疗的非小细胞肺癌患者中恢复细胞免疫力并提高临床疗效?根据PRISMA指南对17项随机对照试验进行荟萃分析
机译:检查点抑制剂加上化疗进行先进的非小细胞肺癌的一线治疗:随机对照试验进行系统审查和荟萃分析